Kenneth Research published a report titled “Breast Lesion Localization Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global breast lesion localization market in terms of market segmentation by type, biopsy techniques, end users and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current ¬¬and future market trends that are associated with the growth of the market.
Access full description of the report: https://www.kennethresearch.com/report-details/breast-lesion-localization-methods-market/10070619
The global breast lesion localization market catered the approximate revenue of USD 520 million in the year 2021 and is estimated to grow at a CAGR of ~10% over the forecast period, i.e., 2022 – 2031. On the basis of type, the market is segmented into wire localization, radioisotope localization, radioactive seed localization, radio occult lesion localization, magnetic tracers and others. Out of these segments, the wire localization segment is anticipated to grow at a moderate CAGR during the forecast period on the back of high accuracy in tissue localization, increasing adoption of the surgical method among surgeons, along with successful outcome of the surgery.
Breast lesion localization is a technique applied to locate abnormalities such as a lump, or tumor, in the breasts. The issue of breast lumps is not restricted to any particular age. The market is primarily driven by the rising incidences of breast cancer, increasing number of breast cancer screening programs, and improvement in reimbursement policies. In addition, the increasing investments for research and development of devices to treat breast cancer, improvement in healthcare facilities and growing awareness about early detection of breast cancer are few major factors contributing to the growth of the market.
Based on region, the global breast lesion localization market is segmented into five major regions, including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa region. Although, the market in North America held the largest market share in the year of 2021, the market in Asia Pacific region is expected to show tremendous growth with a significant CAGR during the forecast period. The market is expected to grow in this region on the back of rising cases of breast cancer, improvement in healthcare sector, increasing awareness about early diagnosis among patients, and growing need for breast conserving surgery.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Growing Incidences of Breast Cancer to Drive the Growth of Breast Lesion Localization Market
The incidences of breast cancer doubled in the past decade. According to the World Health Organization (WHO), 2.3 million women were diagnosed with breast cancer while reporting 685000 deaths around the world in the year 2020. Breast cancer is one of the most common types of cancer that affects women besides skin cancer. The continuously growing number of patients affected with breast cancer is estimated to be the major factors driving the growth of the global breast lesion localization market.
However, high cost of products & treatment and lack of skilled professionals is expected to operate as key restraint to the growth of global breast lesion localization market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global breast lesion localization market which includes company profiling MOLLI Surgical Inc., ARGON MEDICAL., Merit Medical Systems, CP Medical, STERYLAB S.r.l., Cook Group Incorporated, Becton, Dickinson and Company (BD), Hologic, Inc., Zimmer Biomet, and PerkinElmer Inc. among others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global breast lesion localization market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request sample copy of the report: https://www.kennethresearch.com/sample-request-10070619
Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email:
[email protected]
U.S. Phone: +1 313 462 0609